Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy.
Hiroki OsumiHiroshi KawachiToshiyuki YoshioSatoshi IdaNoriko YamamotoYusuke HoriuchiAkiyoshi IshiyamaToshiaki HirasawaTomohiro TsuchidaNaoki HikiKengo TakeuchiJunko FujisakiPublished in: Journal of gastroenterology (2019)
pT1b EBVGC is a convincing candidate for ER, regardless of risk factors other than lymphovascular invasion.